Published date: 21 August 2017

Last edited date: 21 August 2017

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 4 September 2017

Contract summary

Industry

  • Health services - 85100000

Location of contract

London

Value of contract

£0

Procurement reference

BIP271134461

Published date

21 August 2017

Closing date

4 September 2017

Contract start date

1 February 2018

Contract end date

31 January 2021

Contract type

Service contract

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

Text to be corrected in the original notice:
Place of text to be modified: II.1.4
Instead of: Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary service for patients who are housebound, and the use of INRstar software for dosing advice and data reporting. Initial 3 year contract from 1 January 2018 - 31 December 2020, with the option to extend for up to a further two years. Annual contract value is £292,000
Read: Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary service for patients who are housebound, and the use of INRstar software for dosing advice and data reporting. Initial 3 year contract from 1 February 2018 - 31 January 2021, with the option to extend for up to a further two years. Annual contract value is £292,000
Other additional information: Due to the level of interest in this project and the need to ensure sufficient time to identify and mobilise a provider, the start date for this contract will now be 1st February 2018.\"
Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary

More information

Links

About the buyer

Address

Kirkdale House
7 Kirkdale Road
London
E11 1HP
UK

Telephone

+442036881543

Email

nelcsu.welcpod-procurement@nhs.net